ArticlePloS one2025
Facilitators, barriers, and strategies for the implementation of peer-led tuberculosis active case finding among people who use drugs in Dar es Salaam, Tanzania.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobally, tuberculosis (TB) is the leading cause of death from a single infectious agent. In 2023, an estimated 2.7 million cases of TB were undiagnosed or unreported. To address missing cases, the World Health Organization recommends systematic screening for TB. This is synonymous to active case finding (ACF) and involves provider-initiated screening and testing for TB. Despite the high incidence and prevalence of TB among people who use drugs (PWUD), there is a significant gap in data, on their perspectives, regarding the implementation of TB ACF services. This study aimed to explore facilitators and barriers to implementing peer-led TB ACF, as perceived by both, current and potential service users.
methodsWe conducted in-depth interviews among purposively selected adult PWUD in Dar-es-Salaam region, Tanzania. Study participants included: (1) peer PWUD with prior history of illicit drug use and medication-assisted treatment (MAT) (n = 10), (2) current medication-assisted treatment service users receiving clinic-based daily methadone (n = 8), and (3) community PWUD not on MAT recruited from various community locations (n = 4). All peer PWUD were experienced in TB ACF. Thematic content analysis was utilized with the support of NVivo12.
resultsOur findings are presented into two categories: individual and structural, with three main themes pertaining to peer-led TB ACF: (1) facilitators (2) facilitators for targeted improvement and optimization and (3) barriers. A critical facilitator was the acceptability of peer PWUD in providing TB ACF services. Key facilitators for targeted improvement and optimization included the TB screening tool, mobile TB diagnostic services, integrated methadone/TB services, and monetary incentives to peer PWUD. Barriers included inadequate adherence to infection prevention and control (IPC) measures when providing TB ACF services resulting in a reluctance to wear face masks due to stigma, misconceptions that prior TB preventive therapy among peers negates their need for continued IPC adherence, high mobility of PWUD and the fear of withdrawal symptoms associated with the use of anti-TB medication. Due to this fear, many PWUD preferred not to take anti-TB, as they were concerned about the potential severity of withdrawal symptoms.
conclusionOur findings highlight the crucial role of peer-led approaches in enhancing TB ACF among PWUD. Peer acceptance as service providers highlights the potential of community-driven interventions. Strengthening facilitators and addressing challenges is key to optimizing these services. Future research should explore the feasibility of providing peer-supported TB diagnosis and treatment services at friendly drop-in centers. RECOMMENDATIONS: 1. Strengthen mobile diagnostic services by increasing their frequency and coverage, enabling timely diagnosis and treatment. 2. Enhance the TB symptom screening tool by including a symptom-independent test, such as a chest X-ray, as the symptoms of illicit drug use can mask and mimic TB symptoms making diagnosis challenging. 3. Address stigma and misconceptions through peer-led education and awareness campaigns that utilize audio-visual materials tailored to PWUD. This will promote adherence to IPC measures and create a more supportive environment for TB ACF activities. 4. Use anti-TB with minimal interactions with opiates or shorter TB treatment regimens to prevent withdrawal symptoms and improve adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.